curcumin and Virus-Diseases

curcumin has been researched along with Virus-Diseases* in 4 studies

Reviews

3 review(s) available for curcumin and Virus-Diseases

ArticleYear
Antiviral Therapeutic Potential of Curcumin: An Update.
    Molecules (Basel, Switzerland), 2021, Nov-19, Volume: 26, Issue:22

    The treatment of viral disease has become a medical challenge because of the increasing incidence and prevalence of human viral pathogens, as well as the lack of viable treatment alternatives, including plant-derived strategies. This review attempts to investigate the trends of research on in vitro antiviral effects of curcumin against different classes of human viral pathogens worldwide. Various electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar were searched for published English articles evaluating the anti-viral activity of curcumin. Data were then extracted and analyzed. The forty-three studies (published from 1993 to 2020) that were identified contain data for 24 different viruses. The 50% cytotoxic concentration (CC50), 50% effective/inhibitory concentration (EC50/IC50), and stimulation index (SI) parameters showed that curcumin had antiviral activity against viruses causing diseases in humans. Data presented in this review highlight the potential antiviral applications of curcumin and open new avenues for further experiments on the clinical applications of curcumin and its derivatives.

    Topics: Antiviral Agents; Curcumin; Humans; Virus Diseases

2021
Curcumin as an Antiviral Agent.
    Viruses, 2020, 10-31, Volume: 12, Issue:11

    Curcumin, the primary curcuminoid compound found in turmeric spice, has shown broad activity as an antimicrobial agent, limiting the replication of many different fungi, bacteria and viruses. In this review, we summarize recent studies supporting the development of curcumin and its derivatives as broad-spectrum antiviral agents.

    Topics: Animals; Antiviral Agents; Curcuma; Curcumin; DNA Viruses; Humans; Mice; RNA Viruses; Virus Diseases

2020
Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases.
    Recent patents on anti-infective drug discovery, 2012, Volume: 7, Issue:2

    Herbal products have gained considerable interest among the pharmaceutical companies and consumers due to the minimal side effects associated with them. The bioflavanoids present in these products are the key players in modulating their effects. Several therapeutic effects have been attributed to the bioflavanoids present in green tea and turmeric. Antimicrobial activity is one among the spectrum of activities they exhibit. Curcumin and catechins, the principle components of turmeric and green tea respectively have virucidal and virustatic actions. An antimicrobial composition consisting of extracts from green tea and turmeric have shown to be highly potent against various microbes, especially viruses. In the present review, we have discussed the patents and the antiviral effects of curcumin and catechins. The antimalarial effect of curcumin has also been discussed.

    Topics: Anti-Infective Agents; Curcuma; Flavonoids; Humans; Plant Preparations; Tea; Virus Diseases

2012

Other Studies

1 other study(ies) available for curcumin and Virus-Diseases

ArticleYear
IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1.
    Cellular microbiology, 2007, Volume: 9, Issue:12

    Temporal relationship between viral and bacterial infections has been observed, and may arise via the action of virus-induced inflammatory cytokines. These, by upregulating epithelial receptors targeted by bacteria, may encourage greater bacterial infiltration. In this study, human epithelial cells exposed to interferon-gamma but not tumour necrosis factor-alpha or interleukin 1-beta supported increased meningococcal adhesion and invasion. The increase was related to Opa but not Opc or pili adhesin expression. De novo synthesis of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a major Opa receptor, occurred in epithelial cells exposed to the cytokine, or when infected with Opa-expressing bacteria. Cell line-dependent differences in invasion that were observed could be correlated with CEACAM expression levels. There was also evidence for Opa/pili synergism leading to high levels of monolayer infiltration by capsulate bacteria. The use of nuclear factor-kappa B (NFkappaB) inhibitors, diferuloylmethane (curcumin) and SN50, abrogated bacterial infiltration of both untreated and interferon-gamma-treated cells. The studies demonstrate the importance of CEACAMs as mediators of increased cellular invasion under conditions of inflammation and bring to light the potential role of NFkappaB pathway in Opa-mediated invasion by meningococci. The data imply that cell-surface remodelling by virally induced cytokines could be one factor that increases host susceptibility to bacterial infection.

    Topics: Adhesins, Bacterial; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Bacterial Adhesion; Bacterial Outer Membrane Proteins; Carrier Proteins; Cell Adhesion Molecules; Cell Line; Curcumin; Epithelial Cells; Humans; Interferon-gamma; Neisseria meningitidis; NF-kappa B; Peptide Fragments; Peptides; Up-Regulation; Virus Diseases

2007